Novartis Investigative Site

Ribeirão Preto

0 studies enrolling now · 1 studies all time

What they study most

Chronic Myeloid Leukemia

Studies at this site

• Expanded Access Program of AMN107 in Imatinib-resistant or Intolerant Adult Patients With Chronic Myeloid Leukemia — NO_LONGER_AVAILABLE